Therapeutic Drug Monitoring of Clozapine: An Unexpected Outcome
- 1 June 2000
- journal article
- case report
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 22 (3) , 323-324
- https://doi.org/10.1097/00007691-200006000-00015
Abstract
A patient is described who died with the diagnosis of septicemia. After her death the delayed results of a clozapine determination for TDM were sent to the clinician. The clozapine serum level was 4034 μg/L, which was considered to be the primary cause of death. However, a forensic autopsy revealed unexpected metastases of unknown origin with gross liver involvement. Thus the high clozapine levels were judged to be secondary to liver failure. This case is an example of an unexpected outcome of TDM.Keywords
This publication has 7 references indexed in Scilit:
- Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine.Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1998
- Acute Clozapine Overdose: Plasma Concentration and OutcomePharmacopsychiatry, 1998
- Clozapine-induced agranulocytosis: a case report Immunopathophysiological considerationsThe Netherlands Journal of Medicine, 1998
- Pharmacokinetic interactions involving clozapineThe British Journal of Psychiatry, 1997
- Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional studyPsychopharmacology, 1995
- Mechanisms of Clozapine†-Induced AgranulocytosisDrug Safety, 1992
- Risk factors for adverse drug reactions ? epidemiological approachesEuropean Journal of Clinical Pharmacology, 1990